Citation Impact
Citing Papers
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro
2006 StandoutNobel
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
IFN-α-Induced Murine B16 Melanoma Cancer Vaccine Cells: Induction and Accumulation of Cell-Associated IL-15
2007
Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism
2009 StandoutNobel
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
2009 StandoutNobel
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Challenges and successes in developing new therapies for hepatitis C
2005 Nature
Vaccination for hepatitis C virus: closing in on an evasive target
2011
The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection
2002
Antiviral interactions of an HCV polymerase inhibitor with an HCV protease inhibitor or interferon in vitro
2006
Nonstructural protein 3‐4A: the Swiss army knife of hepatitis C virus
2011
A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus
2006
Comprehensive Analyses of CD8+ T Cell Responses During Longitudinal Study of Acute Human Hepatitis C *
2005
Chronic Infections with Hepatotropic Viruses: Mechanisms of Impairment of Cellular Immune Responses
2007
Adaptive immune responses in acute and chronic hepatitis C virus infection
2005 Nature
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27–restricted human immune response
2009
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
Dynamic Hepatitis C Virus Genotypic and Phenotypic Changes in Patients Treated With the Protease Inhibitor Telaprevir
2007
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
The face of future hepatitis C antiviral drug development: Recent biological and virologic advances and their translation to drug development and clinical practice
2005
Technology Insight: confocal laser endoscopy for in vivo diagnosis of colorectal cancer
2007
The influence of T cell cross-reactivity on HCV-peptide specific human T cell response
2006
The remarkable metal-catalysed olefin metathesis reaction
2007 StandoutNature
Imaging in the era of molecular oncology
2008 StandoutNature
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
2010
Discordant Role of CD4 T-Cell Response Relative to Neutralizing Antibody and CD8 T-Cell Responses in Acute Hepatitis C
2006
Characterization of full‐length hepatitis C virus genotype 4 sequences
2006
The hepatitis C virus replicon system: From basic research to clinical application
2005
Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies
2007 StandoutNobel
Cytochrome P450IID6‐specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2†
2007
Preferential loss of IL‐2–secreting CD4+ T helper cells in chronic HCV infection†
2005
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
2011
Delayed Induction, Not Impaired Recruitment, of Specific CD8+ T Cells Causes the Late Onset of Acute Hepatitis C
2011 StandoutNobel
Prolonged Activation of Virus-Specific CD8+T Cells after Acute B19 Infection
2005
The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
2012
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Hepatitis B virus infection
2009 Standout
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner
2009
PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection
2010
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003
2004
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Intrahepatic CD8+ T-Cell Failure During Chronic Hepatitis C Virus Infection *
2005
Treating viral hepatitis C: efficacy, side effects, and complications
2006
Ulcerative colitis
2012 Standout
Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution
2006
Antiviral strategies in hepatitis C virus infection
2012
Adaptive Immunity to the Hepatitis C Virus
2010
T cells and viral persistence: lessons from diverse infections
2005
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
2014
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
2015 StandoutNobel
Long-term follow-up after successful interferon therapy of acute hepatitis C
2004
Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes
2005
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Cancer immunotherapy comes of age
2011 StandoutNature
Hepatitis C Virus-Specific Directly Acting Antiviral Drugs
2013
Viral hepatitis C
2003
Novel Cd4+ and Cd8+ T–Cell Determinants Within the Ns3 Protein in Subjects With Spontaneously Resolved Hcv Infection
2003
Suppression of Hcv–Specific T Cells Without Differential Hierarchy Demonstrated Ex Vivo In Persistent Hcv Infection
2003
Hepatitis C Virus Entry
2007 StandoutNobel
Effects of antiviral therapy on the cellular immune response in acute hepatitis C
2004
Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C
2006
SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 Nonresponders
2007
Rapid Decline of Viral RNA in Hepatitis C Patients Treated With VX-950: A Phase Ib, Placebo-Controlled, Randomized Study
2006
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Viral and cellular RNA helicases as antiviral targets
2005
What Are the Promising New Therapies in the Field of Chronic Hepatitis C After the First-Generation Direct-Acting Antivirals?
2012
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines
2008
Kinetics of the Immune Response During Hbv and Hcv Infection
2003
Clinical significance of elevated serum interferon‐ inducible protein‐10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels
2001
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Replication of hepatitis C virus
2007 StandoutNobel
Cellular immune selection with hepatitis C virus persistence in humans
2005
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
The Impairment of CD8 Responses Limits the Selection of Escape Mutations in Acute Hepatitis C Virus Infection
2005
Antiviral Combination Therapy for Treatment of Chronic Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection
2008
Broad Repertoire of the CD4+ Th Cell Response in Spontaneously Controlled Hepatitis C Virus Infection Includes Dominant and Highly Promiscuous Epitopes
2005
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
2007 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation
2006 StandoutNobel
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Heterologous T cell immunity in severe hepatitis C virus infection
2005
CD8 Epitope Escape and Reversion in Acute HCV Infection
2004
Conserved Hierarchy of Helper T Cell Responses in a Chimpanzee during Primary and Secondary Hepatitis C Virus Infections
2004
Development of an Intergenotypic Hepatitis C Virus (HCV) Cell Culture Method To Assess Antiviral Susceptibilities and Resistance Development of HCV NS3 Protease Genes from HCV Genotypes 1 to 6
2010
Genetic diversity and evolution of hepatitis C virus – 15 years on
2004
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
Convergent Synthesis of the Quinolone Substructure of BILN 2061 via Carbonylative Sonogashira Coupling/Cyclization
2006
Stealth and Cunning: Hepatitis B and Hepatitis C Viruses
2005
Immunizations with Chimeric Hepatitis B Virus-Like Particles to Induce Potential Anti-Hepatitis C Virus Neutralizing Antibodies
2007
Drug resistance against HCV NS3/4A inhibitors is defined by the balance of substrate recognition versus inhibitor binding
2010
Use of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5′ Untranslated Region Sequences
2007
SCY-635, a Novel Nonimmunosuppressive Analog of Cyclosporine That Exhibits Potent Inhibition of Hepatitis C Virus RNA ReplicationIn Vitro
2009
Characterization of Human Antiviral Adaptive Immune Responses during Hepatotropic Virus Infection in HLA-Transgenic Human Immune System Mice
2013 StandoutNobel
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
2003 StandoutNobel
Future Therapies for Hepatitis C
2006
Cutting Edge: Chronic Inflammatory Liver Disease in Mice Expressing a CD28-Specific Ligand
2012 StandoutNobel
Mutations Conferring Resistance to a Hepatitis C Virus (HCV) RNA-Dependent RNA Polymerase Inhibitor Alone or in Combination with an HCV Serine Protease Inhibitor In Vitro
2005
Cell-Mediated Immunity and the Outcome of Hepatitis C Virus Infection
2004
A spatial view of the CD8+ T‐cell response: the case of HCV
2011
Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C Virus
2004 StandoutNobel
Ribavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2′- C -Methylcytidine, the Active Component of Valopicitabine
2006
RCM of Tripeptide Dienes Containing a Chiral Vinylcyclopropane Moiety: Impact of Different Ru-Based Catalysts on the Stereochemical Integrity of the Macrocyclic Products
2005
Works of Markus Reiser being referenced
Full-Breadth Analysis of CD8 + T-Cell Responses in Acute Hepatitis C Virus Infection and Early Therapy
2005
Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients
2004
Feasibility and Diagnostic Utility of Video Capsule Endoscopy for the Detection of Small Bowel Polyps in Patients with Hereditary Polyposis Syndromes
2005
Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection
1997
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection
2004
Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study
2005
Antiviral efficacy of NS3‐serine protease inhibitor BILN‐2061 in patients with chronic genotype 2 and 3 hepatitis C†‡
2005
Colonic cancer and polyps
2002
Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities
2002
Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level
2008
136 Antiviral effect of BILN 2061, a novel HCV serine protease inhibitor, after oral treatment over 2 days in patients with chronic hepatitis C, non-genotype 1
2003
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment
2009